Integralność śródbłonka naczyniowego regulowana w sposób IgE-zależny

ARTYKUŁ PRZEGLĄDOWY

Integralność śródbłonka naczyniowego regulowana w sposób IgE-zależny

Paulina Gorzelak-Pabis 1 , Emilia Luczak 1 , Katarzyna Wojdan 1 , Karolina Antosik 2 , Maciej Borowiec 2 , Marlena Broncel 1 , Maciej Chalubinski 1

1. Department of Internal Diseases and Clinical Pharmacology, The Laboratory of Tissue Immunopharmacology, Medical University of Lodz, Poland
2. Immunopathology and Genetics Laboratory, Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Poland

Opublikowany: 2017-03-02
DOI: 10.5604/01.3001.0010.3800
GICID: 01.3001.0010.3800
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2017; 71 : 162-169

 

Abstrakt

Przypisy

  • 1. Acharya M., Borland G., Edkins A.L., Maclellan L.M., Matheson J., Ozanne B.W., Cushley W.: CD23/FcεRII: molecular multi-tasking. Clin. Exp. Immunol., 2010; 162: 12-23
    Google Scholar
  • 2. Akdis M., Burgler S., Crameri R., Eiwegger T., Fujita H., Gomez E., Klunker S., Meyer N., O›Mahony L., Palomares O., Rhyner C., Ouaked N., Schaffartzik A., Van De Veen W., Zeller S, et al.: Interleukins, from 1 to 37, and interferon-g: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol., 2011; 127: 701-721.e70
    Google Scholar
  • 3. Bax H.J., Keeble A.H., Gould H.J.: Cytokinergic IgE action in mast cell activation. Front. Immunol., 2012; 3: 229
    Google Scholar
  • 4. Chalubinski M., Wojdan K., Luczak E., Gorzelak P., Borowiec M., Gajewski A., Rudnicka K., Chmiela M., Broncel M.: IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms. Vascul. Pharmacol., 2015; 73: 57-63
    Google Scholar
  • 5. Chalubinski M., Zemanek K., Skowron W., Wojdan K., Gorzelak P., Broncel M.: The effect of 7-ketocholesterol and 25-hydroxycholesterol on the integrity of the human aortic endothelial and intestinal epithelial barriers. Inflamm. Res., 2013; 62: 1015-1023
    Google Scholar
  • 6. Chung K.F.: Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J. Intern. Med., 2016; 279: 192-204
    Google Scholar
  • 7. Detoraki A., Di Capua L., Varricchi G., Genovese A., Marone G., Spadaro G.: Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study. J. Asthma, 2016; 53: 201-206
    Google Scholar
  • 8. Djukanović R., Wilson S.J., Kraft M., Jarjour N.N., Steel M., Chung K.F., Bao W., Fowler-Taylor A., Matthews J., Busse W.W., Holgate S.T., Fahy J.V.: Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am. J. Respir. Crit. Care Med., 2004; 170: 583-593
    Google Scholar
  • 9. Fitzsimmons C.M., Falcone F.H., Dunne D.W.: Helminth allergens, parasite-specific IgE, and its protective role in human immunity. Front. Immunol., 2014; 5: 61
    Google Scholar
  • 10. Froidure A., Mouthuy J., Durham S.R., Chanez P., Sibille Y., Pilette C.: Asthma phenotypes and IgE responses. Eur. Respir. J., 2016; 47: 304-319
    Google Scholar
  • 11. Ganesan L.P., Kim J., Wu Y., Mohanty S., Phillips G.S., Birmingham D.J., Robinson J.M., Anderson C.L.: FcgRIIb on liver sinusoidal endothelium clears small immune complexes. J. Immunol., 2012; 189: 4981-4988
    Google Scholar
  • 12. Ishikawa T., Takizawa T., Iwaki J., Mishima T., Ui-Tei K., Takeshita T., Matsubara S., Takizawa T.: Fc gamma receptor IIb participates in maternal IgG trafficking of human placental endothelial cells. Int. J. Mol. Med., 2015; 35: 1273-1289
    Google Scholar
  • 13. Kounis N.G.: Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin. Chem. Lab. Med., 2016; 54: 1545-1559
    Google Scholar
  • 14. Kounis N.G., Mazarakis A., Tsigkas G., Giannopoulos S., Goudevenos J.: Kounis syndrome: a new twist on an old disease. Future Cardiol., 2011; 7: 805-824
    Google Scholar
  • 15. Leslie M.: Mast cells show their might. Science, 2007; 31: 614-616
    Google Scholar
  • 16. Lippi G., Buonocore R., Schirosa F., Cervellin G.: Cardiac troponin I is increased in patients admitted to the emergency department with severe allergic reactions. A case-control study. Int. J. Cardiol., 2015; 194: 68-69
    Google Scholar
  • 17. MacGlashan D.Jr.: IgE receptor and signal transduction in mast cells and basophils. Curr. Opin. Immunol., 2008; 20: 717-723
    Google Scholar
  • 18. Stone K.D., Prussin C., Metcalfe D.D.: IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol., 2010; 125 (Suppl. 2): S73- S80
    Google Scholar
  • 19. Szczeklik A., Sladek K., Szczerba A., Dropinski J.: Serum immunoglobulin E response to myocardial infarction. Circulation, 1988; 77: 1245-1249
    Google Scholar
  • 20. Turner H., Kinet J.P.: Signalling through the high-affinity IgE receptor FcεRI. Nature, 1999; 402 (Suppl. 6760): B24-B30
    Google Scholar
  • 21. Wang J., Cheng X., Xiang M.X., Alanne-Kinnunen M., Wang J.A., Chen H., He A., Sun X., Lin Y., Tang T.T., Tu X., Sjöberg S., Sukhova G.K., Liao Y.H., Conrad D.H., et al.: IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. J. Clin. Invest., 2011; 121: 3564-3577
    Google Scholar
  • 22. Wang L., Gao S., Xu W., Zhao S., Zhou J., Wang N., Yuan Z.: Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice. J. Mol. Cell. Cardiol., 2014; 72: 20-27
    Google Scholar

Pełna treść artykułu

Przejdź do treści